Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly and NYSE:LLY |
776,94 B | 23,56% | 6/6 | 34,75% | 15,97% | 43,96% | DOWN |
|
Johnson & Johnson NYSE:JNJ |
542,44 B | 5,26% | 5/5 | 7,04% | -22,75% | 14,94% | UP |
|
Merck NYSE:MRK |
272,26 B | 7,67% | 6/6 | -21,36% | -2,92% | 22,47% | UP |
|
Pfizer NYSE:PFE |
152,39 B | 7,82% | 4/6 | -5,31% | 22,26% | 2,65% | UP |
|
Bristol-Myers Squibb NYSE:BMY |
117,97 B | 1,77% | 5/6 | -0,30% | 0,64% | 10,76% | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
108,36 B | 13,44% | 6/6 | 6,43% | 1,70% | 31,33% | DOWN |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
75,75 B | 9,26% | 5/6 | 5,41% | 5,58% | 18,53% | UP |
|
Zoetis NYSE:ZTS |
49,57 B | 9,80% | 6/6 | 7,18% | 47,43% | 23,02% | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
24,85 B | 15,13% | 5/6 | 2,41% | -45,84% | 16,40% | UP |
|
Viatris NasdaqGS:VTRS |
17,25 B | -3,69% | 4/6 | 2,85% | -49,95% | 14,79% | UP |
|
Madrigal Pharmaceuticals NasdaqGS:MDGL |
11,93 B | 0,00% | 2/4 | 0,00% | 0,00% | 24,40% | UP |
|
Catalent NYSE:CTLT |
11,52 B | -5,82% | 2/6 | 27,69% | -22,42% | 0,03% | UP |
|
Cytokinetics NasdaqGS:CYTK |
7,65 B | -1,08% | 1/6 | 4,92% | -34,11% | 51,79% | UP |
|
Balchem NasdaqGS:BCPC |
5,60 B | 8,75% | 6/6 | 8,46% | 0,53% | 15,77% | UP |
|
Indivior Pharmaceuticals NasdaqGS:INDV |
4,05 B | 28,91% | 5/6 | 13,62% | -8,05% | 9,21% | UP |
|
TG Therapeutics NasdaqCM:TGTX |
5,23 B | 63,45% | 3/5 | 33,54% | 92,83% | 30,02% | UP |
|
Corcept Therapeutics NasdaqCM:CORT |
4,96 B | 10,36% | 5/6 | 118,76% | 12,89% | 29,81% | DOWN |
|
Ligand Pharmaceuticals NasdaqGM:LGND |
4,85 B | 7,83% | 5/6 | 3,60% | -78,23% | 4,84% | UP |
|
Nektar Therapeutics NasdaqCM:NKTR |
2,93 B | 65,15% | 4/6 | 74,02% | -521,71% | 72,93% | UP |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
2,85 B | 2,48% | 3/6 | 8,61% | -25,93% | 29,40% | UP |
